Meritage Portfolio Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,350
Closed -$450K 297
2020
Q4
$450K Sell
2,350
-74,965
-97% -$13.6M 0.03% 212
2020
Q3
$11.4M Sell
77,315
-191
-0.2% -$27.3K 1.02% 22
2020
Q2
$9.58M Buy
77,506
+2,921
+4% +$344K 0.92% 26
2020
Q1
$7.2M Buy
+74,585
New +$7.2M 0.98% 27

Other funds holding RGEN

Meritage Portfolio Management's RGEN Position: Q1 2021 in Review

Meritage Portfolio Management sold out of Repligen (RGEN) in Q1 2021, closing a stake of 2,350 shares — an estimated $450K sold.

Meritage Portfolio Management first reported a position in RGEN in Q1 2020 and held it in 4 quarters. The position peaked at $11.4M in Q3 2020. 458 funds tracked by Wall St. Rank hold RGEN as of Q1 2021.

  • Meritage Portfolio Management reported no remaining Repligen position as of Q1 2021 after selling out during the quarter.
  • Meritage Portfolio Management sold 2,350 Repligen shares in Q1 2021, an estimated $450K.
  • Meritage Portfolio Management first reported a position in Repligen in Q1 2020 and held it in 4 quarters.
  • Meritage Portfolio Management's Repligen position peaked at $11.4M in Q3 2020.
  • 458 funds tracked by Wall St. Rank held Repligen as of Q1 2021.

Based on Meritage Portfolio Management's 13F filing for Q1 2021, filed 27 Apr 2021.